Long-term impact on workplace status after radical prostatectomy

A recent Norwegian study has concluded that pre-surgical counseling of men electing treatment for prostate cancer by radical prostatectomy needs to include advice about risk for the possibility of post-surgical issues that may affect work status and their working life 3 years after their surgery. … READ MORE …

Most “top-rated” web sites advocate shared decision-making about screening

Despite the recommendations of the USPSTF and others, “Only 17 percent of top-ranked consumer health websites advise against screening for prostate cancer” according to a paper just presented by researchers at the the 2014 Clinical Congress of the American College of Surgeons (ACS), currently ongoing in San Francisco. … READ MORE …

Can Google help to better diagnose cancer?

There’s a lot of hype today about a new initiative of the Google X research group, which has announced that it is investigating the use of nanoparticles to identify early signs of all sorts of disorders from fatty plaques that can cause a heart attack or stroke to early signs of cancer. … READ MORE …

The PrKT03 trial of radiation + immunotherapy for localized prostate cancer

Back in September 2011, a company called Advantagene initiated a randomized, placebo-controlled, Phase III clinical trial (the PrKT01 trial) of an immunotherapeutic agent known as AdV-tk, together with with standard external beam radiation therapy, in highly-defined patients with newly diagnosed, localized prostate cancer. … READ MORE …

Who have you been spending intimate time with?

A paper just published in Cancer Epidemiology makes some striking claims about prostate cancer and sexual behavior that are likely to need to be thoroughly validated. … READ MORE …

CTFPHC rejects widespread screening for risk of prostate cancer

The Canadian Task Force on Preventive Health Care (CTFPHC) has just issued a guidance document that is not going to make most prostate cancer survivors very happy (either in Canada or elsewhere). … READ MORE …

GDF-15, vitamin D, and risk for prostate cancer

A new study by Lambert et al. in the journal Prostate proposes that some forms of chronic prostatic inflammation, driven by low levels of a molecule known as growth differentiation factor-15 (GDF-15), may lead to prostate cancer development. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,157 other followers